Page 26 - Iontech News Today

U.S. regulators on Tuesday authorized a COVID-19 booster shot for healthy 5- to...

The Biden administration said it would make eight more free, at-home COVID tests...

EUA is based on data that show children 5 through 11 years of age had a robust immune response with a favorable safety profile following a 10-µg booster dose of the Pfizer-BioNTech COVID-19 Vaccine

Waning demand threatens efforts to produce vaccine locally so perhaps education is the priority

Pfizer is starting to put its COVID-19 cash influx to use by spending $11.6 billion to...

By Cecilia Butini BioNTech SE on Monday posted revenue and net profit for the first quarter which more than tripled on-year, and backed its outlook for 2022, including on revenues from its... | May 9, 2022

Opinion: How the vaccine has made it all over the world , Local Opinion, Portland local Opinion, Breaking Opinion alerts for Portland city.

Pfizer still figures it will pull in $32 billion and $22 billion in sales of its COVID-19 vaccine Comirnaty and oral antiviral Paxlovid this year.

Survey results suggest a lack of enthusiasm among healthcare professionals and the general public for an additional dose of COVID vaccines.

The Department of Public Health and Social Services reported 68 new cases of COVID-19 Tuesday from 903 specimens analyzed on Monday.